2022 European guideline for the management of balanoposthitis
Journal of the European Academy of Dermatology and Venereology · 2023-06 · 37 (6) · 1104-1117
DOI: 10.1111/jdv.18954 ↗Kurz gefasst
Leitlinie in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, online erschienen am 21.03.2023. Verfasst von Sarah K Edwards und 3 weiteren Autor:innen. Beteiligte Einrichtung: iCasH Suffolk, Abbey View Clinic, Bury St Edmunds, UK. Hauptthemen laut MEDLINE: Balanitis, Circumcision, Male, Penile Diseases, Penile Neoplasms. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 101 Literaturangaben.
Abstract (Originalsprache)
Background
This guideline is an update to the 2014 edition of the European guideline for the management of balanoposthitis. Balanoposthitis describes inflammation of the glans penis and prepuce and is caused by a range of disparate conditions including infection, dermatoses and premalignancy.
Objective
The main objectives of this guideline are to aid recognition of the symptoms and signs and complications of penile skin conditions and to offer recommendations on the diagnostic tests and treatment for a selected group of these conditions.
Methods
The previous guideline was updated following a literature review and priority was given to randomized controlled trial and systematic review evidence.
Results
The updated guideline includes amended management for infective balanitis to provide clear guidance for Group A streptococcal infections, management of on going Lichen sclerosus (to include circumcision and supportive management to reduce the recurrence of genital herpes and warts), additional regimens for Zoonoid change, use of calcineurin inhibitors in management and risk of premalignancy and change of nomenclaturefrom Premalignant conditions to Penile Intraepithelial neoplasia (PeIN).
Conclusion
Balanoposthitis has a widerange of causes high quality evidence specific to the management of penile disease is not available for all the conditions described.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- iCasH Suffolk, Abbey View Clinic, Bury St Edmunds, UK.
- Department of Dermatology, University College London Hospitals, London, UK.
- Department of Dermatology, Central Military Hospital, Utrecht, The Netherlands.
- Department of Dermatology, Betsi Cadwaladr University Health Board (BCUHB), Bangor, UK.
ORCID-Profile: Sarah K Edwards, Christopher B Bunker
Zitieren
APA
Edwards, S. K., Bunker, C. B., van der Snoek, E. M., & van der Meijden, W. I. (2023). 2022 European guideline for the management of balanoposthitis. Journal of the European Academy of Dermatology and Venereology, 37(6), 1104-1117. https://doi.org/10.1111/jdv.18954
Vancouver
Edwards SK, Bunker CB, van der Snoek EM, van der Meijden WI. 2022 European guideline for the management of balanoposthitis. Journal of the European Academy of Dermatology and Venereology. 2023;37(6):1104-1117. doi:10.1111/jdv.18954
BibTeX
@article{Edwards2023,
author = {Edwards, Sarah K and Bunker, Christopher B and van der Snoek, Eric M and van der Meijden, Willem I},
title = {2022 European guideline for the management of balanoposthitis},
journal = {Journal of the European Academy of Dermatology and Venereology},
year = {2023},
volume = {37},
number = {6},
pages = {1104--1117},
doi = {10.1111/jdv.18954}
}
EUVIMED